TF and neoplasm: Abrogation of TF function in TNBC or PaC cells via ShRNA or TF-mAb SC1 blocked tumor-initiated coagulation process, inhibited TF-PAR2-dependent MAPK/ERK phosphorylation cascade and attenuated tumor growth and metastasis.